Rainbow Medical raises $ 25 million from Chinese investors, and establishes an Office of China for Strategic Partnerships.
Rainbow Medical, a R & D and operational investment company, specializing in planting and incubation of new medical device companies and development of innovative medical technologies, has raised $ 25 million from investors in China and opened an office in China to promote strategic partnerships.
"We opened the office in Shanghai to capitalize on rapidly growing China market for our products and to foster collaboration with Chinese medical device companies," said Efi Cohen-Arazi, Co-founder and CEO of Rainbow Medical.
"These investments by major industrial and financial institutions Chinese it is an expression of the high esteem with which they see our technologies and products that we are developing," he said, adding: "There is a strong demand in the industry of Chinese health fast growth of advanced technologies of medical Rainbow ".
Participants in the current round of fundraising include holding largest private insurance company China Ping An, investment and management company financial YongJin, the Chinese telecom giant ZTE Corporation, and venture capital funds Chinese.
Rainbow Medical invest the funds in planting new startup companies based on intellectual property owned by Rainbow Medical, and to provide additional funding for existing portfolio companies including medical Rainbow:
Nano Retina, the developer of an ultra-small artificial retina designed to restore vision to the blind; Biomedical Enopace, the developer of a neuro-stimulator aortic minimally invasive treatment of chronic heart failure; Medical BlueWind, the developer of a platform minimally invasive neuro stimulation to treat a wide range of neurological indications wireless implant; GluSense, continuous developer implantable glucose sensor for diabetes patients; and Vascular Dynamics, such a developer to an implantable stent for the treatment of hypertension device.
About Rainbow Medical:
Rainbow Medical, a privately operating investment, currently has a portfolio of 12 companies that are developing products for the treatment of a wide range of chronic indications such as heart disease, diabetes, hypertension, blindness, uterine fibroids, neuropathic pain chronic, and others.
Rainbow Medical raised significant funds for strategic entities worldwide, including giant Medtronic and Abbott, the European Sorin Group and Japan's Sony Corporation medical devices.
Rainbow Medical was founded by GLENROCK Israel, an investment company specializing in private equity technology and life sciences are owned by Leon Recanati, one of the leading business figures from Israel; Yossi Gross, an industry world-renowned entrepreneur medical devices; Efi Cohen-Arazi and one of the executives in the life science industry's most respected widely in Israel.
TheChinaInvestors is the world's #1 funding and investments network for Chinese Investors and Global Investees.